Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19
An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confir...
Saved in:
Published in | Health and quality of life outcomes Vol. 19; no. 1; pp. 40 - 10 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
03.02.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19.
Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale.
1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire.
We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. |
---|---|
AbstractList | An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19.
Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale.
1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire.
We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire. We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Methods Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. Results 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire. Conclusion We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. Keywords: SARS-CoV-2, Functional status, Symptoms, Quality of life Abstract Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Methods Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. Results 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing ‘slight’, ‘moderate’ and ‘severe’ functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing ‘negligible’ and ‘no’ functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233–0.661). Notably, the strongest association found was with the ‘usual activities’ domain of the 5-level EQ-5D questionnaire. Conclusion We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Methods Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. Results 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing ‘slight’, ‘moderate’ and ‘severe’ functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing ‘negligible’ and ‘no’ functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233–0.661). Notably, the strongest association found was with the ‘usual activities’ domain of the 5-level EQ-5D questionnaire. Conclusion We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19.BACKGROUNDAn increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19.Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale.METHODSAdult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale.1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire.RESULTS1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire.We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.CONCLUSIONWe demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms. |
ArticleNumber | 40 |
Audience | Academic |
Author | Vaes, Anouk W. Meys, Roy Houben-Wilke, Sarah Boon, Gudula J. A. M. Spies, Yvonne Vijlbrief, Herman Rezek, Spencer A. van Herck, Maarten Posthuma, Rein Klok, Frederikus A. Delbressine, Jeannet M. van ’t Hul, Alex Franssen, Frits M. E. Siegerink, Bob Pitta, Fabio Burtin, Chris Janssen, Daisy J. A. Goërtz, Yvonne M. J. Spruit, Martijn A. Barco, Stefano Machado, Felipe V. C. |
Author_xml | – sequence: 1 givenname: Felipe V. C. orcidid: 0000-0003-1910-7695 surname: Machado fullname: Machado, Felipe V. C. – sequence: 2 givenname: Roy surname: Meys fullname: Meys, Roy – sequence: 3 givenname: Jeannet M. surname: Delbressine fullname: Delbressine, Jeannet M. – sequence: 4 givenname: Anouk W. surname: Vaes fullname: Vaes, Anouk W. – sequence: 5 givenname: Yvonne M. J. surname: Goërtz fullname: Goërtz, Yvonne M. J. – sequence: 6 givenname: Maarten surname: van Herck fullname: van Herck, Maarten – sequence: 7 givenname: Sarah surname: Houben-Wilke fullname: Houben-Wilke, Sarah – sequence: 8 givenname: Gudula J. A. M. surname: Boon fullname: Boon, Gudula J. A. M. – sequence: 9 givenname: Stefano surname: Barco fullname: Barco, Stefano – sequence: 10 givenname: Chris surname: Burtin fullname: Burtin, Chris – sequence: 11 givenname: Alex surname: van ’t Hul fullname: van ’t Hul, Alex – sequence: 12 givenname: Rein surname: Posthuma fullname: Posthuma, Rein – sequence: 13 givenname: Frits M. E. surname: Franssen fullname: Franssen, Frits M. E. – sequence: 14 givenname: Yvonne surname: Spies fullname: Spies, Yvonne – sequence: 15 givenname: Herman surname: Vijlbrief fullname: Vijlbrief, Herman – sequence: 16 givenname: Fabio surname: Pitta fullname: Pitta, Fabio – sequence: 17 givenname: Spencer A. surname: Rezek fullname: Rezek, Spencer A. – sequence: 18 givenname: Daisy J. A. surname: Janssen fullname: Janssen, Daisy J. A. – sequence: 19 givenname: Bob surname: Siegerink fullname: Siegerink, Bob – sequence: 20 givenname: Frederikus A. surname: Klok fullname: Klok, Frederikus A. – sequence: 21 givenname: Martijn A. surname: Spruit fullname: Spruit, Martijn A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33536042$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhSNURB_wB1ggS2xgkeJH_MgGqRpaGKlSEQNsLcePGY8ycYnt0v57nE5bOhVCXtiyv3N8fX0Oq70hDLaqXiN4jJBgHyLCLaU1xKiGiLWoxs-qA9RwXnOK6d6j9X51GOMaQkwwpi-qfUIoYbDBB5WchSGmMesErlTvjU83IDiQVhZ8DTHVs4uf8081asFZHnTyYVA9WCSVcgQLrXoL_ACUyX0CMXdrq1MEv31agXvdy-q5U320r-7mo-rH2en32Zf6_OLzfHZyXmva8lQz2iChBKWu0diKDhsnoLDEwK5hSqiGGwwdYw5pYy1xHcFdI5igiLfCWEyOqvnW1wS1lpej36jxRgbl5e1GGJdSjcnr3srycs1Ry3SHYLkVt85iqBtDO844Qrx4fdx6XeZuY422QxpVv2O6ezL4lVyGK8kFZQxPxby7MxjDr2xjkhsfte17NdiQo8Sl9IZhQUhB3z5B1yGPpcsT1aIGlweiv9SytFz6wYVyr55M5QkrXykI4lPdx_-gyjB243XJjvNlf0fwfkdQmGSv01LlGOV88W2XffO4KQ_duI9SAfAW0GOIcbTuAUFQTnmV27zKkld5m1c5icQTkfYlXSVnpXTf_0_6B39I6cM |
CitedBy_id | crossref_primary_10_3389_fresc_2023_1186499 crossref_primary_10_1007_s10554_023_02819_9 crossref_primary_10_22289_2446_922X_V10N1A31 crossref_primary_10_1136_bmjgh_2021_006838 crossref_primary_10_1371_journal_pone_0312735 crossref_primary_10_1590_1980_5764_dn_2021_0116 crossref_primary_10_12688_f1000research_133999_1 crossref_primary_10_12688_f1000research_133999_2 crossref_primary_10_1093_cid_ciad143 crossref_primary_10_3390_ijerph19159273 crossref_primary_10_3390_brainsci11111456 crossref_primary_10_3390_ijerph18116017 crossref_primary_10_55905_cuadv16n10_029 crossref_primary_10_15446_rsap_v25n3_107343 crossref_primary_10_3390_jcm13216626 crossref_primary_10_12688_f1000research_133999_3 crossref_primary_10_3390_jcm12020624 crossref_primary_10_3390_jcm10235594 crossref_primary_10_1155_2022_8373697 crossref_primary_10_1183_23120541_00141_2021 crossref_primary_10_1186_s12879_021_06970_3 crossref_primary_10_1038_s41598_022_17033_1 crossref_primary_10_1371_journal_pone_0279310 crossref_primary_10_1016_j_cegh_2024_101695 crossref_primary_10_20473_jn_v17i2_36170 crossref_primary_10_12968_ijtr_2022_0096 crossref_primary_10_1055_s_0043_1764467 crossref_primary_10_3390_ijerph192214739 crossref_primary_10_3390_healthcare12070730 crossref_primary_10_1055_a_1946_3230 crossref_primary_10_1007_s00103_022_03513_2 crossref_primary_10_1183_13993003_02174_2021 crossref_primary_10_1016_j_resmer_2022_100973 crossref_primary_10_1186_s41687_024_00748_2 crossref_primary_10_12688_f1000research_127398_1 crossref_primary_10_1093_cid_ciab352 crossref_primary_10_2196_30274 crossref_primary_10_3390_epidemiologia3010006 crossref_primary_10_3390_jcm11195904 crossref_primary_10_1080_13854046_2024_2379508 crossref_primary_10_1590_1809_2950_e22008824pt crossref_primary_10_1136_bmjopen_2024_084202 crossref_primary_10_2196_33704 crossref_primary_10_1055_a_2059_4844 crossref_primary_10_1177_23969873221092538 crossref_primary_10_1016_j_ijosm_2022_04_004 crossref_primary_10_1038_s41598_023_30674_0 crossref_primary_10_1016_j_jbmt_2023_11_002 crossref_primary_10_2147_IJGM_S492772 crossref_primary_10_4187_respcare_12089 crossref_primary_10_1186_s13293_024_00609_z crossref_primary_10_1016_j_bjpt_2023_100503 crossref_primary_10_1016_j_clinbiomech_2022_105797 crossref_primary_10_1055_a_1551_9734 crossref_primary_10_1080_17474086_2023_2277323 crossref_primary_10_3389_fmed_2021_750378 crossref_primary_10_1590_1809_2950_e22008824en crossref_primary_10_1002_pmrj_13141 crossref_primary_10_1177_15500594221103834 crossref_primary_10_2196_44241 crossref_primary_10_3390_biomedicines12112445 crossref_primary_10_1080_09638288_2024_2303366 crossref_primary_10_1186_s12879_025_10729_5 crossref_primary_10_3390_healthcare10122577 crossref_primary_10_1177_11795735231195693 crossref_primary_10_1093_infdis_jiae270 crossref_primary_10_1016_j_pulmoe_2022_01_001 crossref_primary_10_1590_1413_81232025301_05682023 crossref_primary_10_3390_ijerph191811460 crossref_primary_10_1016_j_ft_2023_03_126 crossref_primary_10_1016_j_thromres_2022_11_006 crossref_primary_10_3390_jpm13091391 crossref_primary_10_1590_0102_311xen026623 crossref_primary_10_18203_issn_2454_2156_IntJSciRep20250388 crossref_primary_10_3389_fimmu_2024_1341600 crossref_primary_10_1186_s13063_024_08032_w crossref_primary_10_3390_jcm11247338 crossref_primary_10_1590_0102_311xpt026623 crossref_primary_10_1016_j_iccn_2022_103366 crossref_primary_10_18093_0869_0189_2021_31_5_571_579 crossref_primary_10_1016_j_rpth_2024_102534 crossref_primary_10_1016_j_thromres_2021_08_012 crossref_primary_10_1038_s41598_024_71589_8 crossref_primary_10_1007_s44202_024_00204_8 crossref_primary_10_1136_bmjresp_2021_001136 crossref_primary_10_1055_s_0042_1749659 crossref_primary_10_1177_29768675241305102 crossref_primary_10_1007_s00508_025_02522_w crossref_primary_10_1186_s40945_022_00147_0 crossref_primary_10_3390_healthcare11162277 crossref_primary_10_3390_biology10060469 crossref_primary_10_4274_tybd_galenos_2023_03360 crossref_primary_10_1016_j_arbres_2021_09_008 crossref_primary_10_1093_ptj_pzac090 crossref_primary_10_18093_0869_0189_2023_33_5_611_621 crossref_primary_10_31083_j_rcm2302053 |
Cites_doi | 10.1016/j.jpainsymman.2016.10.370 10.1007/s11136-005-8661-z 10.1371/journal.pone.0211532 10.1186/1477-7525-2-51 10.2165/00019053-199304050-00006 10.1183/23120541.00542-2020 10.1136/thx.2004.030205 10.1007/s40273-016-0441-9 10.1038/s41586-020-2405-7 10.1016/j.thromres.2020.04.041 10.1001/archinte.167.12.1312 10.1126/science.abb3221 10.1016/j.thromres.2019.04.003 10.1016/j.jval.2016.01.003 10.1016/j.thromres.2020.03.020 10.3390/jcm9092946 10.1016/j.jclinepi.2010.02.006 10.1111/j.1440-1843.2010.01720.x 10.1001/jama.2020.2648 10.1089/jpm.2010.0438 10.1183/13993003.01494-2020 10.3390/jcm9123993 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7T2 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BENPR BHPHI C1K CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. M0S M1P PATMY PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PYCSY 7X8 5PM DOA |
DOI | 10.1186/s12955-021-01691-2 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database Environmental Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals (WRLC) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1477-7525 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_360c7196cb1041829fe20c4d5b767117 PMC7856622 A653683177 33536042 10_1186_s12955_021_01691_2 |
Genre | Journal Article |
GeographicLocations | Belgium Netherlands United States--US |
GeographicLocations_xml | – name: Netherlands – name: Belgium – name: United States--US |
GroupedDBID | --- 0R~ 29I 2WC 44B 53G 5VS 7X7 7XC 88E 8C1 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACHQT ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR IPY ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PATMY PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PYCSY RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7T2 7XB 8FK AZQEC C1K COVID DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c597t-65418a855f4c2e8b2df808e3d0b46a8a47d20f66f1cdee3fb32b486851798de23 |
IEDL.DBID | M48 |
ISSN | 1477-7525 |
IngestDate | Wed Aug 27 01:30:39 EDT 2025 Thu Aug 21 14:12:43 EDT 2025 Fri Jul 11 08:39:37 EDT 2025 Fri Jul 25 03:45:45 EDT 2025 Mon Aug 11 06:00:10 EDT 2025 Tue Jun 10 20:49:29 EDT 2025 Fri Jun 27 04:19:26 EDT 2025 Mon Jul 21 05:44:33 EDT 2025 Tue Jul 01 04:06:47 EDT 2025 Thu Apr 24 23:01:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Functional status SARS-CoV-2 Symptoms Quality of life |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c597t-65418a855f4c2e8b2df808e3d0b46a8a47d20f66f1cdee3fb32b486851798de23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1910-7695 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12955-021-01691-2 |
PMID | 33536042 |
PQID | 2491421791 |
PQPubID | 44384 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_360c7196cb1041829fe20c4d5b767117 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7856622 proquest_miscellaneous_2486462833 proquest_journals_2491421791 gale_infotracmisc_A653683177 gale_infotracacademiconefile_A653683177 gale_incontextgauss_ISR_A653683177 pubmed_primary_33536042 crossref_primary_10_1186_s12955_021_01691_2 crossref_citationtrail_10_1186_s12955_021_01691_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-02-03 |
PublicationDateYYYYMMDD | 2021-02-03 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Health and quality of life outcomes |
PublicationTitleAlternate | Health Qual Life Outcomes |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 1691_CR13 1691_CR12 D Hui (1691_CR18) 2017; 53 MM Versteegh (1691_CR21) 2016; 19 A Bardel (1691_CR26) 2019; 14 R Li (1691_CR3) 2020; 368 M Fortin (1691_CR25) 2006; 15 PSJ Miller (1691_CR23) 2016; 34 DS Hui (1691_CR6) 2005; 60 M Fortin (1691_CR24) 2004; 2 MC Reilly (1691_CR22) 1993; 4 FA Klok (1691_CR9) 2019; 178 FA Klok (1691_CR8) 2020; 56 LB Mokkink (1691_CR17) 2010; 63 YMJ Goërtz (1691_CR14) 2020; 6 S Flaxman (1691_CR4) 2020; 584 FA Klok (1691_CR11) 2020; 191 JC Ngai (1691_CR7) 2010; 15 Z Wu (1691_CR2) 2020; 323 1691_CR1 L Zeng (1691_CR19) 2011; 14 AW Vaes (1691_CR15) 2020; 9 GJAM Boon (1691_CR10) 2020; 190 R Meys (1691_CR16) 2020; 9 CM Tansey (1691_CR5) 2007; 167 1691_CR20 |
References_xml | – volume: 53 start-page: 630 issue: 3 year: 2017 ident: 1691_CR18 publication-title: J Pain Symptom Manag doi: 10.1016/j.jpainsymman.2016.10.370 – volume: 15 start-page: 83 issue: 1 year: 2006 ident: 1691_CR25 publication-title: Qual Life Res doi: 10.1007/s11136-005-8661-z – volume: 14 start-page: e0211532 issue: 2 year: 2019 ident: 1691_CR26 publication-title: PLoS ONE doi: 10.1371/journal.pone.0211532 – volume: 2 start-page: 51 year: 2004 ident: 1691_CR24 publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-2-51 – volume: 4 start-page: 353 issue: 5 year: 1993 ident: 1691_CR22 publication-title: Pharmacoeconomics doi: 10.2165/00019053-199304050-00006 – ident: 1691_CR1 – volume: 6 start-page: 00542 issue: 4 year: 2020 ident: 1691_CR14 publication-title: ERJ Open Res doi: 10.1183/23120541.00542-2020 – volume: 60 start-page: 401 issue: 5 year: 2005 ident: 1691_CR6 publication-title: Thorax doi: 10.1136/thx.2004.030205 – volume: 34 start-page: 1277 issue: 12 year: 2016 ident: 1691_CR23 publication-title: Pharmacoeconomics doi: 10.1007/s40273-016-0441-9 – volume: 584 start-page: 257 issue: 7820 year: 2020 ident: 1691_CR4 publication-title: Nature doi: 10.1038/s41586-020-2405-7 – volume: 191 start-page: 148 year: 2020 ident: 1691_CR11 publication-title: Thromb Res doi: 10.1016/j.thromres.2020.04.041 – ident: 1691_CR12 – volume: 167 start-page: 1312 issue: 12 year: 2007 ident: 1691_CR5 publication-title: Arch Intern Med doi: 10.1001/archinte.167.12.1312 – volume: 368 start-page: 489 issue: 6490 year: 2020 ident: 1691_CR3 publication-title: Science doi: 10.1126/science.abb3221 – volume: 178 start-page: 59 year: 2019 ident: 1691_CR9 publication-title: Thromb Res doi: 10.1016/j.thromres.2019.04.003 – volume: 19 start-page: 343 issue: 4 year: 2016 ident: 1691_CR21 publication-title: Value Health doi: 10.1016/j.jval.2016.01.003 – volume: 190 start-page: 45 year: 2020 ident: 1691_CR10 publication-title: Thromb Res doi: 10.1016/j.thromres.2020.03.020 – volume: 9 start-page: 2946 issue: 9 year: 2020 ident: 1691_CR15 publication-title: J Clin Med doi: 10.3390/jcm9092946 – ident: 1691_CR20 – volume: 63 start-page: 737 issue: 7 year: 2010 ident: 1691_CR17 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.02.006 – volume: 15 start-page: 543 issue: 3 year: 2010 ident: 1691_CR7 publication-title: Respirology doi: 10.1111/j.1440-1843.2010.01720.x – volume: 323 start-page: 1239 issue: 13 year: 2020 ident: 1691_CR2 publication-title: JAMA doi: 10.1001/jama.2020.2648 – volume: 14 start-page: 337 issue: 3 year: 2011 ident: 1691_CR19 publication-title: J Palliat Med doi: 10.1089/jpm.2010.0438 – volume: 56 start-page: 2001494 issue: 1 year: 2020 ident: 1691_CR8 publication-title: Eur Respir J doi: 10.1183/13993003.01494-2020 – volume: 9 start-page: 3993 issue: 12 year: 2020 ident: 1691_CR16 publication-title: J Clin Med doi: 10.3390/jcm9123993 – ident: 1691_CR13 |
SSID | ssj0023225 |
Score | 2.580799 |
Snippet | An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on... Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its... Abstract Background An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 40 |
SubjectTerms | Adult Belgium Committees Convalescence Coronaviruses COVID-19 COVID-19 - physiopathology COVID-19 - psychology COVID-19 diagnostic tests Cross-Sectional Studies Demographic aspects Disease Domains Evaluation Female Functional Status Health aspects Hospitalization Humans Hypotheses Impairment Indexing Infections Male Medical ethics Middle Aged Netherlands Quality of Life Questionnaires Reproducibility of Results SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Signs and symptoms Surveys and Questionnaires Symptoms Thromboembolism Validation studies Validity Viral diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_SU0HE-rlaSxTBg4RuPjabd2yrj9aDgrXSW9h82QeyT9i-_78zye7jLQW9eN1Mwu7MJDOTnfkNIe-lMDXEDZLhXyemNLZ5aYJhMugEHkbnfMhZvl_1-ZX6ct1c77T6wpywAg9cGHcsde1bUBPvIHAAZ3iRoqi9Co1rdct5riMHmzcFU2OohWo6lcgYfTyAVWuwEhlDZ73gTMzMUEbrv38m7xilecLkjgVaPiaPRteRnpRXPiAPYv-EPCz3brSUEz0lFjtwZkxYCjq0CuBk03Wi4OZR7MvLzr79vPjE-IIuwaCVe0CKDudmoJcgrkhXPc2YHHTYOLyjGShe1dJp3jNytfz84-ycjU0UmIdY4ZZhn2_TmaZJyotonAgJpBNlqJ3SnelUG0SdtE7chxhlclI4ZbTJSGYhCvmc7PXrPr4kVEkRo-rMItRBmQ6W5Z5z7WSCVSJXFeETT60fEcax0cVvmyMNo22RgwU52CwHKyrycTvnT8HX-Cv1KYpqS4nY2PkBaIwdNcb-S2Mq8g4FbRH9osf0ml_dZhjsxeV3e6IbqQ24VED0YSRKa_gG343VCsAJBMyaUR7OKGF7-vnwpE92PB4GCzEvVwKRYSvydjuMMzHlrY_rDdIYjYXDUlbkRVG_7XdLCcvDcVuRdqaYM8bMR_rVTQYPbw048EK8-h-cfE32Rd5TArb6IdkD7Y5vwEe7dUd5O94BruMx1w priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9UwDI9gXJAQ4puOgQJC4oCiNR9N805oDJ42DiAxht4tar62J6F2rHv_P3bavq1C2rVxojZ2HNu1fybkvRSmBL9BMvzrxJTGNi9VMEwGncDCaJwPOcv3uz46Vd9W1WoMuPVjWuWkE7OiDp3HGPk-uAlcCQTT_HTxl2HXKPy7OrbQuEvuIXQZpnTVq2uHC4V1KpQxer-Hu63CemR0oPWCMzG7jDJm__-a-cbVNE-bvHEPLR-Rh6MBSQ8Gjj8md2L7hDwYom90KCp6Siz24czIsBQkaR3A1KZdomDsUezOyw5__D7-wviCLuFaG6KBFM3OTU9PgGmRrluakTlov3EYqekpBmzpNO8ZOV1-_XV4xMZWCsyDx3DFsNu3aUxVJeVFNE6EBDyKMpRO6cY0qg6iTFon7kOMMjkpnDLaZDyzEIV8Tnbaro0vCVVSxKgaswhlUKaBZbnnXDuZYJXIVUH4tKfWjzjj2O7ij83-htF24IMFPtjMBysK8nE752JA2biV-jOyakuJCNn5QXd5ZscDZ6UufQ3qxTtwOMGJWqQoSq9C5Wpdc14X5B0y2iIGRotJNmfNpu_t8clPe6ArqQ0YVkD0YSRKHXyDb8aaBdgJhM2aUe7NKOGQ-vnwJE92VBK9vRbpgrzdDuNMTHxrY7dBGqOxfFjKgrwYxG_73VLC8qB0C1LPBHO2MfORdn2eIcRrA2a8ELu3v9Yrcl_k0yLgKO-RHZDb-BpssCv3Jh-0f6WyKsg priority: 102 providerName: ProQuest |
Title | Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33536042 https://www.proquest.com/docview/2491421791 https://www.proquest.com/docview/2486462833 https://pubmed.ncbi.nlm.nih.gov/PMC7856622 https://doaj.org/article/360c7196cb1041829fe20c4d5b767117 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfG9oKEEN8LjMogJB5QIP6I7T4gtJZNGxIDdRRVvFiJ7YxKUwrLKsF_z52TVIuYEC95qM-u4rvzfcT3O0JeCG4yiBtEil-dUqmwzUvuTSq8qsDDKErn4y3fE3U0lx8W-WKL9O2Oug1srg3tsJ_U_OL89a-fv9-Bwr-NCm_UmwZsVo51xhgYqzFL4UjeAcukUVE_ys1XBY7CG6uNtE51zvO-iObaNQaGKuL5_31qXzFbwyuVV2zU4R1yu3Mu6X4rDXfJVqjvkVttZo62BUf3icUenRE1loKULT244XRVUXAEKXbuTaefvh6_T9mYHoLJazOFFF3SdUNPgaGBLmsaUTtosy4xi9NQTObSft4DMj88-DI9Srs2C6mDaOIyxU7gpjB5XknHgym5r4B_QfislKowhdSeZ5VSFXM-BFGVgpfSKBOxznzg4iHZrld12CVUCh6CLMzYZ16aApZljjFVigpWCUwmhPV7al2HQY6tMM5tjEWMsi0fLPDBRj5YnpBXmzk_WgSOf1JPkFUbSkTPjj-sLs5sp4xWqMxpOHpcCcEoBFjjKvDMSZ-XWmnGdEKeI6Mt4mPUeAHnrFg3jT0-ndl9lQtlwOkCopcdUbWCd3BFV88AO4GQWgPKvQElKLAbDvfyZHv5txAVM8kROzYhzzbDOBMvxdVhtUYao7C0WIiEPGrFb_PeQsDycCAnRA8Ec7Axw5F6-T3Ci2sDLj7nj__jf5-QmzyqDAdd3yPbILzhKThpl-WI3NALDU8zZSOyMzk4-TwbxYTHKOokPGeTb38AOEk3NQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0KrKASSEeBMoxSAQBxQ1fsTxHirUB6tdWopEW7Q3N7GdshJKCukK8VP9RmacZNsIqbde47GVeN6TeRDyVnCdgN8gYvzrFEuFY15Sp2PhVAkWRl5YF7J8D9TkWH6epbMVctHXwmBaZS8Tg6B2tcUY-Qa4CUxybKb58exXjFOj8O9qP0KjJYs9__cPuGzN5nQX8PuO8_Gno51J3E0ViC0Yz-cxDr7WuU7TUlrudcFdCa_rhUsKqXKdy8zxpFSqZNZ5L8pC8EJqFWbYa-ex0QGI_FugeBPkqGx26eAhc_SFOVptNKBLU6x_RoddjVjMB8ovzAj4XxNcUYXDNM0rem98n9zrDFa61VLYA7Liq4fkbhvto20R0yNicO5n6ERLgXLnDkx7WpcUjEuK04Djna_fp7sxG9ExqNE2-kjRzF009BCIxNN5RUMnENosCowMNRQDxLTf95gc38glPyGrVV35Z4RKwb2XuR65xEmdw7HMMqYKUcIpnsmIsP5Oje36muN4jZ8m-DdamRYPBvBgAh4Mj8iH5Z6ztqvHtdDbiKolJHbkDg_q36emY3AjVGIzEGe2AAcXnLZR6XlipUuLTGWMZRF5g4g22HOjwqSe03zRNGZ6-M1sqVQoDYYcAL3vgMoavsHmXY0E3AS26RpArg0gQSjY4XJPT6YTSo25ZKGIvF4u405MtKt8vUAYrbBcWYiIPG3Jb_ndQsDxIOQjkg0Ic3Axw5Vq_iO0LM80uA2cP7_-tV6R25OjL_tmf3qw94Lc4YFzOIiRNbIKNOxfgv13XqwHpqPk5Ka5_B-9Tmed |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Construct+validity+of+the+Post-COVID-19+Functional+Status+Scale+in+adult+subjects+with+COVID-19&rft.jtitle=Health+and+quality+of+life+outcomes&rft.au=Machado%2C+Felipe+V+C&rft.au=Meys%2C+Roy&rft.au=Delbressine%2C+Jeannet+M&rft.au=Vaes%2C+Anouk+W&rft.date=2021-02-03&rft.issn=1477-7525&rft.eissn=1477-7525&rft.volume=19&rft.issue=1&rft.spage=40&rft_id=info:doi/10.1186%2Fs12955-021-01691-2&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-7525&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-7525&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-7525&client=summon |